H2020
PREFER
Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 68 months
- Total cost
- EUR 12,015,548
- EU contribution
- EUR 6,000,000
- Participants
- 33 from 9 countries
- Topic
- H2020_IMI2-2015-05-01
- Grant agreement
- 115966
Coordinated by Uppsala Universitet (SESweden).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Uppsala Universitet | SESweden | Coordinator | EUR 1,455,667 | known name (0.95) |
| Centre Federal D'Expertise des Soins de Sante | BEBelgium | Participant | EUR 252,500 | known name (0.95) |
| European Cancer Patient Coalition | BEBelgium | Participant | EUR 223,250 | PIC (1.00) |
| Forum des Patients Europeens | BEBelgium | Participant | EUR 65,000 | PIC (1.00) |
| International Strategic Marketing Services (Isms) | BEBelgium | Third party | Not stated | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Katholieke Universiteit Leuven | BEBelgium | Participant | EUR 772,759 | PIC (1.00) |
| Mindbytes | BEBelgium | Participant | EUR 259,937 | PIC (1.00) |
| Actelion Pharmaceuticals Ltd | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Takeda Pharmaceuticals International AG | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Bayer Pharma AG | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Collaborate Project Management Ug Haftungsbeschrankt | DEGermany | Participant | EUR 282,500 | PIC (1.00) |
| Csl Behring GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Universitatsklinikum Erlangen | DEGermany | Participant | EUR 230,722 | known name (0.97) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | EUR 0 | PIC (1.00) |
| AbbVie Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Amgen Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| International Alliance of Patient'organizations | GBUnited Kingdom | Participant | EUR 63,173 | PIC (1.00) |
| Muscular Dystrophy Group of Great Britain and Northern Ireland | GBUnited Kingdom | Participant | EUR 80,000 | PIC (1.00) |
| Takeda Development Centre Europe Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| The University of Birmingham | GBUnited Kingdom | Participant | EUR 241,750 | known name (0.95) |
| Instituto Tumori Giovanni Paolo II | ITItaly | Participant | EUR 25,783 | PIC (1.00) |
| Istituto Europeo di Oncologia SRL | ITItaly | Participant | EUR 496,750 | PIC (1.00) |
| Astellas Pharma Europe BV | NLNetherlands | Participant | EUR 0 | PIC (1.00) |
| Erasmus Universitair Medisch Centrum Rotterdam | NLNetherlands | Participant | EUR 22,513 | PIC (1.00) |
| Erasmus Universiteit Rotterdam | NLNetherlands | Participant | EUR 782,257 | known name (0.95) |
| Universitair Medisch Centrum Utrecht | NLNetherlands | Participant | EUR 480,517 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | EUR 0 | PIC (1.00) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 33 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.